These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 7681287

  • 21. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J, Burns LJ.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
    Robertson MJ, Cameron C, Atkins MB, Gordon MS, Lotze MT, Sherman ML, Ritz J.
    Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
    Stein GM, Berg PA.
    Eur J Med Res; 1999 May 26; 4(5):169-77. PubMed ID: 10336405
    [Abstract] [Full Text] [Related]

  • 29. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).
    Janssen O, Scheffler A, Kabelitz D.
    Arzneimittelforschung; 1993 Nov 26; 43(11):1221-7. PubMed ID: 8292069
    [Abstract] [Full Text] [Related]

  • 30. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
    Cosiski Marana HR, Santana da Silva J, Moreira de Andrade J.
    Gynecol Oncol; 2000 Sep 26; 78(3 Pt 1):318-23. PubMed ID: 10985887
    [Abstract] [Full Text] [Related]

  • 31. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
    Lauria F, Raspadori D, Ventura MA, Rondelli D, Zinzani PL, Gherlinzoni F, Miggiano MC, Fiacchini M, Rosti G, Rizzi S, Tura S.
    Bone Marrow Transplant; 1996 Jul 26; 18(1):79-85. PubMed ID: 8831999
    [Abstract] [Full Text] [Related]

  • 32. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
    Miles EA, Banerjee T, Wells SJ, Calder PC.
    Nutrition; 2006 May 26; 22(5):512-9. PubMed ID: 16600816
    [Abstract] [Full Text] [Related]

  • 33. Immunostimulation by Alsophila spinulosa extract fraction VII of both humoral and cellular immune responses.
    Kao SF, Kuo HL, Lee YC, Chiang HC, Lin YS.
    Anticancer Res; 1994 May 26; 14(6B):2439-43. PubMed ID: 7872664
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
    Petri IB, Szekeres E, Varga E, Berek I, Molnár J, Berek L, Kawase M, Motohashi N.
    Anticancer Res; 1996 May 26; 16(3A):1247-50. PubMed ID: 8702245
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J, Lauerova L, Janakova L, Talac R, Simickova M, Nekulova M, Mikulikova I, Kovarik J, Sheard M.
    Hepatogastroenterology; 1999 May 26; 46(25):220-7. PubMed ID: 10228796
    [Abstract] [Full Text] [Related]

  • 38. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1.
    Gabius HJ.
    Biochimie; 2001 Jul 26; 83(7):659-66. PubMed ID: 11522395
    [Abstract] [Full Text] [Related]

  • 39. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R, Classen K, Berg PA, Lüdtke R, Werner M, Huber R.
    Eur J Med Res; 2002 Apr 30; 7(4):155-63. PubMed ID: 12010650
    [Abstract] [Full Text] [Related]

  • 40. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE.
    Phytother Res; 2009 Mar 30; 23(3):407-11. PubMed ID: 19003944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.